Dr. Khashayar Yazdanbakhsh, MD

Dr. Yazdanbakhsh practices at The New Jewish Home, Harry and Jeanette Weinberg Campus in Bronx, New York.

Dr. Yazdanbakhsh's NPI, 1508097080, was assigned on August 2, 2009. Dr. Yazdanbakhsh holds New York license 269675.

Dr. Yazdanbakhsh's primary practice is The New Jewish Home, Harry and Jeanette Weinberg Campus, at 100 W Kingsbridge Rd, Bronx, NY 10468 in Bronx County. The practice phone is (718) 410-1500.

Dr. Yazdanbakhsh's primary practice is The New Jewish Home, Harry and Jeanette Weinberg Campus in Bronx, New York. The medical group on file is Essen Medical Associates. Dmand AI also links Dr. Yazdanbakhsh to 2 more group practices and clinics, 2 hospices, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yazdanbakhsh practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yazdanbakhsh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yazdanbakhsh is licensed in New York.

CMS data shows 1,236 Medicare services from Dr. Yazdanbakhsh across 3 procedure codes in 2024, for 40 Medicare patients. Medicare paid $88,511 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Dr. Yazdanbakhsh in 2024. The largest group is 85 and over, with 16 patients. 75% of them have alzheimer's and dementia, and 75% have high blood pressure. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yazdanbakhsh's median patient age at 78, with 53% women.

In 2024, Dr. Yazdanbakhsh wrote 2,850 Medicare Part D claims for 60 patients. 95% of them were for generic drugs. CMS names the drug for 2,655 of them, across 46 drugs with 11 or more claims each, at $64,171 in total drug cost. In 2023, CMS named 2,653 claims across 50 drugs.

Dr. Yazdanbakhsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 82 general payments to Dr. Yazdanbakhsh from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $2,015.